Barry R. Frankel

Barry Frankel serves as Director of Business Development for BioMed Valley Discoveries. Barry has over 40 years of experience in the life science industry, including company formation and operations, investment research, strategic planning, licensing/mergers/acquisitions, and commercialization. Barry’s recent business development and financing experience includes oncology (Nanocare, BioConvergent, Cireca), inflammation (Metriopharm), infection (Micreos), neurology (NBO, Sedor) and digital health (Elexo/Qey). Barry serves as an Advisor for Marathon Asset Management.

Previously, Barry was Founder of Frankel Group, a global boutique life science strategy consulting firm (acquired by Huron Consulting Group); Partner and President of SJ Weinstein Associates Inc., a healthcare advertising and marketing strategy firm (exited into Bates Healthcare); held senior management positions at Pfizer Pharmaceuticals; and was a Senior Research Officer Life Sciences for Citibank Investment Management Group.